Comment on: oncologic outcomes after robotic pancreatic resections are not inferior to open surgery.
作者信息
Mimmo Antonio, Piardi Tullio
机构信息
Department of Hepatobiliary, Pancreatic and Digestive Oncological Surgery, Robert Debré University Hospital, University of Reims Champagne-Ardenne, Reims, France.
Research Unit Ea3797 VieFra, Department of Hepatobiliary, Pancreatic and Digestive Oncological Surgery, Robert Debré University Hospital, University of Reims Champagne-Ardenne, Reims, France.
出版信息
Hepatobiliary Surg Nutr. 2021 Dec;10(6):842-845. doi: 10.21037/hbsn-21-486.
Abstract
摘要
相似文献
1
Comment on: oncologic outcomes after robotic pancreatic resections are not inferior to open surgery.评论：机器人胰腺切除术后的肿瘤学结果并不逊于开放手术。
Hepatobiliary Surg Nutr. 2021 Dec;10(6):842-845. doi: 10.21037/hbsn-21-486.
2
Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery.机器人胰腺切除术后的肿瘤学结局并不逊于开放手术。
Ann Surg. 2021 Sep 1;274(3):e262-e268. doi: 10.1097/SLA.0000000000003615.
3
Trends and outcomes of robotic surgery for gastrointestinal (GI) cancers in the USA: maintaining perioperative and oncologic safety.美国胃肠道（GI）癌症机器人手术的趋势和结果：维持围手术期和肿瘤学安全性。
Surg Endosc. 2020 Nov;34(11):4932-4942. doi: 10.1007/s00464-019-07284-x. Epub 2019 Dec 9.
4
Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adenocarcinoma: A Single-Center Comparison to Laparoscopic Resection.机器人辅助左半胰切除术治疗胰腺腺癌的肿瘤学结局：与腹腔镜切除术的单中心比较
Am Surg. 2021 Jan;87(1):45-49. doi: 10.1177/0003134820949524. Epub 2020 Sep 11.
5
The current state of robotic-assisted pancreatic surgery.机器人辅助胰腺手术的现状。
Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):468-76. doi: 10.1038/nrgastro.2012.120. Epub 2012 Jun 26.
6
The state of the art of robotic pancreatectomy.机器人胰腺切除术的技术现状。
Biomed Res Int. 2014;2014:920492. doi: 10.1155/2014/920492. Epub 2014 May 28.
7
250 robotic pancreatic resections: safety and feasibility.250 例机器人胰腺切除术：安全性和可行性。
Ann Surg. 2013 Oct;258(4):554-9; discussion 559-62. doi: 10.1097/SLA.0b013e3182a4e87c.
8
Robotic pancreaticoduodenectomy may offer improved oncologic outcomes over open surgery: a propensity-matched single-institution study.机器人胰十二指肠切除术可能比开放手术提供更好的肿瘤学结果：一项倾向评分匹配的单机构研究。
Surg Endosc. 2020 Aug;34(8):3644-3649. doi: 10.1007/s00464-020-07564-x. Epub 2020 Apr 23.
9
Robotic versus Open Level I-II Inferior Vena Cava Thrombectomy: A Matched Group Comparative Analysis.机器人与开放一级-II 下腔静脉血栓切除术：匹配组比较分析。
J Urol. 2017 Dec;198(6):1241-1246. doi: 10.1016/j.juro.2017.06.094. Epub 2017 Jul 8.
10
Outcomes associated with robotic approach to pancreatic resections.与机器人辅助胰腺切除术相关的结果。
J Gastrointest Oncol. 2018 Oct;9(5):936-941. doi: 10.21037/jgo.2018.08.04.
本文引用的文献
1
From Da Vinci Si to Da Vinci Xi: realistic times in draping and docking the robot.从达芬奇Si到达芬奇Xi：机器人铺单与对接的实际操作时代
J Robot Surg. 2020 Dec;14(6):835-839. doi: 10.1007/s11701-020-01057-8. Epub 2020 Feb 20.
2
Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery.机器人胰腺切除术后的肿瘤学结局并不逊于开放手术。
Ann Surg. 2021 Sep 1;274(3):e262-e268. doi: 10.1097/SLA.0000000000003615.
3
Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy.机器人与开放胰十二指肠切除术血管切除术后的手术、生存和肿瘤学结果。
Surg Endosc. 2020 Jan;34(1):377-383. doi: 10.1007/s00464-019-06779-x. Epub 2019 Apr 8.
4
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial.腹腔镜与开腹胰十二指肠切除术治疗胰腺或壶腹周围肿瘤（LEOPARD-2）：一项多中心、患者盲法、随机对照 2/3 期试验。
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):199-207. doi: 10.1016/S2468-1253(19)30004-4. Epub 2019 Jan 24.
5
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.FOLFIRINOX 或吉西他滨作为胰腺癌的辅助治疗。
N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.
6
Meta-analysis of FOLFIRINOX regimen as the first-line chemotherapy for locally advanced pancreatic cancer and borderline resectable pancreatic cancer.FOLFIRINOX 方案作为局部晚期胰腺癌和可切除边界胰腺癌一线化疗的荟萃分析。
Clin Exp Med. 2019 Feb;19(1):149-157. doi: 10.1007/s10238-018-0540-3. Epub 2018 Nov 29.
7
Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient-blinded Randomized Controlled Trial.微创与开腹远端胰腺切除术（LEOPARD）：一项多中心患者盲法随机对照试验。
Ann Surg. 2019 Jan;269(1):2-9. doi: 10.1097/SLA.0000000000002979.
8
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.胰体尾导管腺癌行远端胰腺切除术时的检查淋巴结数量与淋巴结状态评估。
Ann Surg. 2019 Dec;270(6):1138-1146. doi: 10.1097/SLA.0000000000002781.
9
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).胰腺导管腺癌手术中标准淋巴结清扫术的定义：国际胰腺手术研究组（ISGPS）的共识声明
Surgery. 2014 Sep;156(3):591-600. doi: 10.1016/j.surg.2014.06.016. Epub 2014 Jul 22.
10
Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer.术后并发症减少了可切除胰腺癌辅助化疗的使用。
Ann Surg. 2014 Aug;260(2):372-7. doi: 10.1097/SLA.0000000000000378.
Zotero 插件